Withus Pharmaceutical. Co., LTD
Founded in 2004 and listed on KOSDAQ in 2020, Withus Pharmaceutical is a generic and CMO drugmaker focused on cardiovascular medicines.
As of 2026-10-10, Withus Pharmaceutical. Co., LTD has 227 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- 아토렌정Hyperlipidemia treatment (atorvastatin, Lipitor generic)
- 피도그린정Antiatherosclerotic agent
- 브이디핀정Antihypertensive
- 텔미사르탄Antihypertensive (pelletized formulation)
Regulatory approvals
data.go.kr227 Korean MFDS drug approvals · 1988–2026
- MFDS drugRovzet ODT. 10/20mg2026-06-30Drug · Prescription · Approval202601885
- MFDS drugRovzet ODT. 10/10mg2026-06-30Drug · Prescription · Approval202601886
- MFDS drugRovzet ODT. 10/5mg2026-06-30Drug · Prescription · Approval202601887
- MFDS drugPranuka Tab. 50mg2026-06-29Drug · Prescription · Approval202601848
- MFDS drugForxizin Tab. 10mg2026-04-01Drug · Prescription · Approval202600928
- MFDS drugForxizin Tab. 5mg2026-04-01Drug · Prescription · Approval202600929
- MFDS drugV-dipine Tab. 2.5/80mg2026-02-24Drug · Prescription · Approval202600553
- MFDS drugMantini Tab. 5mg2025-12-05Drug · Prescription · Approval202503180
- MFDS drugVitamD soft capsule 0.5mcg(Alfacalcidol)2025-10-01Drug · OTC · Notification202502605
- MFDS drugWITHUCAB Tablet2025-07-14Drug · Prescription · Approval202501770
- MFDS drugWipide SR tab. 150mg2025-06-11Drug · Prescription · Approval202501432
- MFDS drugTasfeno Cap.2025-04-30Drug · Prescription · Approval202501059
Show 68 more
- MFDS drugMantini Tab. 20mg2025-04-16Drug · Prescription · Approval202500919
- MFDS drugMirto Tab. 20mg2025-03-06Drug · Prescription · Approval202500502
- MFDS drugGinbiloba Tab. 240mg2024-10-24Drug · OTC · Notification202402519
- MFDS drugCecl-One MR Tab. 375mg2024-03-27Drug · Prescription · Approval202400678
- MFDS drugWicer Tab. 30mg2024-02-29Drug · Prescription · Approval202400437
- MFDS drugWidiance Duo Tab. 12.5/1000mg2023-09-13Drug · Prescription · Approval202302748
- MFDS drugWidiance Duo Tab 12.5/850mg2023-09-13Drug · Prescription · Approval202302749
- MFDS drugWidiance Duo Tab 12.5/500mg2023-09-13Drug · Prescription · Approval202302750
- MFDS drugForximet XR tab. 5/500mg2022-11-10Drug · Prescription · Approval202204063
- MFDS drugForximet XR tab. 10/500mgRevoked2022-11-10Drug · Prescription · Approval202204064
- MFDS drugWidiance Duo Tab. 5/850mg2022-04-04Drug · Prescription · Approval202201370
- MFDS drugWidiance Duo Tab. 5/1000mg2022-04-04Drug · Prescription · Approval202201371
- MFDS drugWidiance Duo Tab. 5/500mg2022-04-04Drug · Prescription · Approval202201372
- MFDS drugForxirizin Tab.2022-03-11Drug · Prescription · Approval202201028
- MFDS drugEsliptin-M Tab. 50/1000mg2022-03-02Drug · Prescription · Approval202200906
- MFDS drugEsliptin-D Tab. 10/100mg2022-01-28Drug · Prescription · Approval202200491
- MFDS drugEsliptin-M Tab. 50/850mg2022-01-20Drug · Prescription · Approval202200333
- MFDS drugEsliptin-M Tab. 50/500mg2022-01-20Drug · Prescription · Approval202200334
- MFDS drugWirelto Tab. 2.5mg2021-12-29Drug · Prescription · Approval202108132
- MFDS drugRegaba Tab. 25mg2021-12-20Drug · Prescription · Approval202108022
- MFDS drugWithuGood ODF 20mg2021-10-25Drug · Prescription · Approval202107093
- MFDS drugWithuGood ODF 10mg2021-10-25Drug · Prescription · Approval202107094
- MFDS drugForximet XR tab. 10/1000mg2021-10-20Drug · Prescription · Approval202107048
- MFDS drugForximet XR tab. 5/1000mg2021-10-20Drug · Prescription · Approval202107049
- MFDS drugEsrazoleduo20/800mg2021-06-18Drug · Prescription · Approval202104746
- MFDS drugDurotel tab. 80/20mg2021-06-14Drug · Prescription · Approval202104525
- MFDS drugDurotel tab. 80/10mg2021-06-14Drug · Prescription · Approval202104526
- MFDS drugTastin Tab. 4mg2021-04-29Drug · Prescription · Approval202103491
- MFDS drugDurotel tab. 40/20mg2021-04-22Drug · Prescription · Approval202103315
- MFDS drugDurotel tab. 40/10mg2021-04-22Drug · Prescription · Approval202103316
- MFDS drugDurotel Tab. 40/5mg2021-04-22Drug · Prescription · Approval202103317
- MFDS drugWithupezil Tab. 23mg2021-04-05Drug · Prescription · Approval202102936
- MFDS drugTastin Tab. 1mg2021-03-31Drug · Prescription · Approval202102817
- MFDS drugWidiance Tab. 10mg2021-03-05Drug · Prescription · Approval202102099
- MFDS drugWidiance Tab. 25mg2021-03-05Drug · Prescription · Approval202102100
- MFDS drugButimerin Tab.Revoked2021-02-26Drug · OTC · Notification202101918
- MFDS drugAvazet Tab. 10/40mg2021-02-25Drug · Prescription · Approval202101873
- MFDS drugAvazet Tab. 10/20mg2021-02-18Drug · Prescription · Approval202101393
- MFDS drugAvazet Tab. 10/10mg2021-02-18Drug · Prescription · Approval202101394
- MFDS drugWitofanib Tab. 5mgRevoked2021-01-07Drug · Prescription · Approval202100141
- MFDS drugSonperi SR Tab.Revoked2020-06-23Drug · Prescription · Approval202004617
- MFDS drugForxizin Tab. 10mgRevoked2020-06-17Drug · Prescription · Approval202004449
- MFDS drugEsliptin Tab. 100mg2020-05-29Drug · Prescription · Approval202004028
- MFDS drugEsliptin Tab. 50mg2020-05-29Drug · Prescription · Approval202004029
- MFDS drugEsliptin Tab. 25mg2020-05-29Drug · Prescription · Approval202004030
- MFDS drugOlmerosu Tab. 20/20mg2020-05-28Drug · Prescription · Approval202003956
- MFDS drugOlmerosu Tab. 20/10mg2020-05-28Drug · Prescription · Approval202003957
- MFDS drugOlmerosu Tab. 20/5mg2020-05-28Drug · Prescription · Approval202003958
- MFDS drugU-penil Cap.2020-05-27Drug · Prescription · Approval202003924
- MFDS drugIbansan Inj.2020-05-11Drug · Prescription · Notification202003406
- MFDS drugWithupentin Cap. 300mg2020-04-29Drug · Prescription · Approval202003239
- MFDS drugWithupentin Cap. 100mg2020-04-29Drug · Prescription · Approval202003240
- MFDS drugGaspin SR Tab. 15mg2020-04-24Drug · Prescription · Approval202002987
- MFDS drugAtoren Tab. 40mg2020-04-10Drug · Prescription · Approval202002540
- MFDS drugRegaba Tab. 75mg2020-03-31Drug · Prescription · Approval202002264
- MFDS drugRegaba Tab. 50mg2020-03-31Drug · Prescription · Approval202002265
- MFDS drugRegaba Tab. 150mg2020-03-31Drug · Prescription · Approval202002266
- MFDS drugWiprozil Tab.2020-03-25Drug · Prescription · Approval202002098
- MFDS drugV-dio Tab. 80mg2020-03-19Drug · Prescription · Approval202001920
- MFDS drugV-dio Tab. 160mg2020-03-19Drug · Prescription · Approval202001921
- MFDS drugSimva-V Tab.Revoked2020-03-19Drug · Prescription · Approval202001928
- MFDS drugWithus Lafutidine Tab. 10mg2020-03-03Drug · Prescription · Approval202001488
- MFDS drugOlmepine Tab. 5/20mg2020-02-21Drug · Prescription · Approval202001260
- MFDS drugOlmepine Tab. 5/40mg2020-02-21Drug · Prescription · Approval202001261
- MFDS drugOlmepine Tab. 10/40mg2020-02-21Drug · Prescription · Approval202001262
- MFDS drugSarpol SR Tab. 300mg2020-02-20Drug · Prescription · Approval202001222
- MFDS drugCetiaxone Inj. 2g2020-01-07Drug · Prescription · Notification202000104
- MFDS drugCetiaxone Inj. 0.5gRevoked2020-01-07Drug · Prescription · Notification202000103
Showing the 80 most recent of 227 records.
Clinical trials
data.go.kr67 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 63 · Phase 1 4)
- Bioequivalence에스립틴엠정50/1000밀리그램2026-09-17
2 trial sites
- Bioequivalence트윈플러스정80/10mg2026-03-25
2 trial sites
- BioequivalenceWU-24001T2025-11-24
2 trial sites
- Bioequivalence타스젯정4/10밀리그램(피타바스타틴칼슘,에제티미브)2025-10-28
2 trial sites
- Phase 1포시메트서방정10/1000밀리그램2025-07-21
2 trial sites
- BioequivalenceWTU-1020T2025-05-26
2 trial sites
- Bioequivalence에스라졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2025-04-15
2 trial sites
- Phase 1포시메트서방정10/1000밀리그램2025-01-06
2 trial sites
- BioequivalenceWU-24001T2024-12-04
2 trial sites
- Bioequivalence메트포민서방정(메트포르민염산염)2024-07-24
2 trial sites
- BioequivalenceWU-22004T2024-04-23
2 trial sites
- BioequivalenceWU-22004T2024-04-23
2 trial sites
Show 55 more
- Bioequivalence메트포민서방정(메트포르민염산염)2024-03-29
2 trial sites
- Phase 1포시진정10밀리그램2024-03-28
2 trial sites
- Bioequivalence트윈플러스정80/10mg2024-01-16
2 trial sites
- Bioequivalence아토렌정40밀리그램(아토르바스타틴칼슘삼수화물)2023-12-28
2 trial sites
- Phase 1W-2142023-12-01
2 trial sites
- BioequivalenceW-215T2023-11-21
2 trial sites
- Bioequivalence레이프라정20밀리그램(라베프라졸나트륨)2023-11-21
2 trial sites
- Bioequivalence위더스세파클러서방정375밀리그램(세파클러수화물)2023-04-24
2 trial sites
- BioequivalenceWU-22004T2023-03-17
2 trial sites
- BioequivalenceWU-22004T2023-03-09
2 trial sites
- Bioequivalence위더스세파클러서방정375밀리그램(세파클러수화물)2022-12-22
2 trial sites
- Bioequivalence레프로진정(레보드로프로피진)2022-12-19
2 trial sites
- Bioequivalence레티라진정(레보세티리진염산염)2022-12-14
2 trial sites
- Bioequivalence위피드정100밀리그램(레바미피드)2022-05-03
2 trial sites
- Bioequivalence가스핀정(모사프리드시트르산염수화물)2022-02-25
2 trial sites
- Bioequivalence에스라졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2022-01-24
2 trial sites
- Bioequivalence위피드정100밀리그램(레바미피드)2021-11-08
2 trial sites
- Bioequivalence위더콕스캡슐200밀리그램(세레콕시브)2021-10-07
2 trial sites
- Bioequivalence세로아핀정100mg(쿠에티아핀푸마르산염)2021-09-02
2 trial sites
- Bioequivalence레이프라정20밀리그램(라베프라졸나트륨)2021-07-30
2 trial sites
- Bioequivalence아스틴정(아젤라스틴염산염)2021-07-26
2 trial sites
- Bioequivalence위더스파모티딘정20mg2021-07-16
2 trial sites
- Bioequivalence세악틸정(세푸록심악세틸)2021-07-12
2 trial sites
- Bioequivalence위더스세파클러서방정375밀리그램(세파클러수화물)2021-05-11
2 trial sites
- Bioequivalence세프포정(세프포독심프록세틸)2021-03-29
2 trial sites
- Bioequivalence에스라졸정40밀리그램(에스오메프라졸마그네슘삼수화물)2021-03-26
2 trial sites
- Bioequivalence위프로질정(세프프로질수화물)2021-03-25
2 trial sites
- Bioequivalence테르나정(테르비나핀염산염)2021-03-05
2 trial sites
- Bioequivalence타록시드정100밀리그람(오플록사신)2021-02-23
2 trial sites
- Bioequivalence위더세프캡슐(세파드록실수화물)2021-01-21
2 trial sites
- Bioequivalence아레온정10밀리그램(에피나스틴염산염)2020-11-05
2 trial sites
- Bioequivalence팜시스정250mg(팜시클로비르)2020-10-08
2 trial sites
- Bioequivalence소로펜정2020-07-09
2 trial sites
- Bioequivalence아토렌정20밀리그램(아토르바스타틴칼슘삼수화물)2020-06-11
2 trial sites
- Bioequivalence듀로텔정 80/202020-03-17
2 trial sites
- Bioequivalence아바젯정10/20mg2019-11-25
2 trial sites
- Bioequivalence위피드정100밀리그램(레바미피드)2019-09-30
2 trial sites
- Bioequivalence피도그린정75mg(클로피도그렐황산염)2019-09-27
2 trial sites
- Bioequivalence소로펜정2019-09-18
2 trial sites
- Bioequivalence듀로텔정 40/202019-09-06
2 trial sites
- Bioequivalence레가바정75밀리그램(프레가발린)2019-03-06
2 trial sites
- Bioequivalence브이디핀정10/160mg2016-06-08
2 trial sites
- Bioequivalence위더페질정10밀리그램(도네페질염산염)2016-03-14
2 trial sites
- Bioequivalence네오브론캡슐(아세브로필린)2015-10-30
1 trial site
- Bioequivalence로수브이정10mg(로수바스타틴칼슘)2015-10-29
2 trial sites
- Bioequivalence트윈플러스정80/5mg2015-10-16
2 trial sites
- Bioequivalence트루렌정 4밀리그램(실로도신)2015-03-18
2 trial sites
- Bioequivalence로우딘정5mg(암로디핀베실산염)2015-02-13
2 trial sites
- Bioequivalence위더스세프라딘캡슐500mg(세프라딘수화물)2014-04-28
2 trial sites
- Bioequivalence카베올정(카르베딜롤)2013-10-29
2 trial sites
- Bioequivalence미르토플러스정80/12.52013-05-15
2 trial sites
- Bioequivalence미르토정80mg(텔미사르탄)2013-02-28
2 trial sites
- Bioequivalence지스톨정(미소프로스톨)2013-02-01
2 trial sites
- Bioequivalence로바토정5mg/20mg2012-12-10
2 trial sites
- Bioequivalence솔리신정10밀리그램(솔리페나신숙신산염)(가칭)2012-09-17
2 trial sites
R&D and key agreements
Source: DART corporate disclosureIVL-DrugFluidicTM 두타스테리드 전립선비대증치료제 · 전립선비대증 · Licensed in from Inventage Lab with worldwide rights to clinical development, approval, manufacturing, and commercialization.
에페리손염산염 서방정 안정성 개선 기술 · 근골격계 · 특허출원(2019년 4월, 만료 2039년 4월) · Filed a patent in April 2019 for a stability-improvement method for a sustained-release eperisone hydrochloride tablet.
이중정 기반 순환기·근골격용제 파이프라인 · 순환기계·근골격계 · Began developing bilayer-tablet-based generic drugs in February 2017.
Key disclosures
KRX KIND via OpenDARTPatents
KIPRIS · applicant-matchedPublished · 2026-03 · Application 1020260042382
Registered · 2023-05 · Application 1020230064318
Published · 2022-08 · Application 1020220106250
Registered · 2019-04 · Application 1020190038840
Registered · 2012-05 · Application 1020120048090
Registered · 2012-03 · Application 1020120027608
Registered · 2011-03 · Application 1020110021480
Withdrawn · 2006-03 · Application 1020060022574
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive2
- OpenAIOAI-SearchBot68
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Withus Pharmaceutical. Co., LTD and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition